ALUIGI, MICHELA

ALUIGI, MICHELA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.016 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. Leo E;Mancini M;Aluigi M;Luatti S;Castagnetti F;Testoni N;Soverini S;Santucci MA;Martinelli G 2013-01-01 PLOS ONE - 1.01 Articolo in rivista Leo et al_PONE2013.pdf
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia Manuela Mancini;Nevena Veljkovic;Elisa Leo;Michela Aluigi;Enrica Borsi;Chiara Galloni;Ilaria Iaco...bucci;Enza Barbieri;Maria Alessandra Santucci 2012-01-01 JOURNAL OF CELLULAR BIOCHEMISTRY - 1.01 Articolo in rivista -
DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia Leo E.; Mancini M.; Aluigi M.; Castagnetti F.; Martinelli G.; Barbieri E.; Santucci MA. 2012-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor Manuela Mancini;Elisa Leo;Michela Aluigi;Chiara Marcozzi;Enrica Borsi;Enza Barbieri;Maria Alessan...dra Santucci 2012-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Bac...carani; M Cavo 2012-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 Mancini M.; Aluigi M.; Leo E.; Marcozzi C.; Castagnetti F.; Barbieri E.; Santucci MA. 2012-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Inhibition of DNA repair by the small molecule Chk1/Chk2 inhibitor PF-0477736 (Pfizer) in B-acute lymphoblastic leukemia (ALL) Iacobucci I; Cattina F; Pomella S; Brighenti E; Papayannidis C; Derenzini E; Lonetti A; Ferrari A...; Verga Falzacappa MV; Guadagnuolo V; Aluigi M; Ottaviani E; Abbenante MC; Soverini S; Russo D; Pelicci PG; Baccarani M; Martinelli G 2012-01-01 CANCER RESEARCH - 4.02 Riassunto (Abstract) -
HIF 1 Alpha: A Suitable Target for Multiple Myeloma PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI ...P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M 2011-01-01 BLOOD - 4.02 Riassunto (Abstract) -
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Bri...ghenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli 2011-01-01 BLOOD - 1.06 Abstract in rivista -
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. Curti A; Aluigi M; Pandolfi S; Ferri E; Isidori A; Salvestrini V; Durelli I;
Horenstein AL; Fior...
e F; Massaia M; Piccioli M; Pileri SA; Zavatto E; D'Addio A; Baccarani M; Lemoli RM.
2007-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Curti A; Pandolfi S; Valzasina B; Aluigi M; Isidori A; Ferri E; Salvestrini V; Bonanno G; Rutella... S; Durelli I; Horenstein AL; Fiore F; Massaia M; Colombo MP; Baccarani M; Lemoli RM. 2007-01-01 BLOOD - 1.01 Articolo in rivista -
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Lemoli R; Catani L; Talarico S; Loggi E; Gramenzi A; Baccarani U; Fogli M; Grazi G; Aluigi M; Mar...zocchi G; Bernardi M; Pinna A; Bresadola F; Baccarani M; Andreone P. 2006-01-01 STEM CELLS - 1.01 Articolo in rivista -
NUCLEOFECTION IS AN EFFICIENT NON-VIRAL TRANSFECTION TECHNIQUE FOR HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS. ALUIGI M.; FOGLI M.; CURTI A.; ISIDORI A.; GRUPPIONI E.; CHIODONI C.; COLOMBO MP.; VERSURA P.; D'...ERRICO-GRIGIONI A.; FERRI E.; BACCARANI M.; LEMOLI R. 2006-01-01 STEM CELLS - 1.01 Articolo in rivista -
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Curti A.; Pandolfi S.; Aluigi M.; Isidori A.; Alessandrini I.; Chiodoni C.;
Testoni N.; Colombo ...
MP.; Baccarani M.; Lemoli RM.
2005-01-01 EXPERIMENTAL HEMATOLOGY - 1.01 Articolo in rivista -
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. LEMOLI RM; FERRARI D; FOGLI M; ROSSI L; PIZZIRANI C; FORCHAP S; CHIOZZI P; VASELLI D; BERTOLINI F...; FOUTZ T; ALUIGI M; BACCARANI M.; DI VIRGILIO F. 2004-01-01 BLOOD - 1.01 Articolo in rivista -